Valuation Metrics and Recent Changes
As of 27 May 2026, Laxmi Organic’s price-to-earnings (P/E) ratio stands at 53.44, a figure that, while still elevated, marks a moderation from previous levels that classified the stock as very expensive. The price-to-book value (P/BV) ratio is 2.14, indicating that the market values the company at just over twice its book value. Other valuation multiples include an enterprise value to EBIT (EV/EBIT) of 49.49 and an EV to EBITDA of 27.36, both of which remain high relative to typical industry standards.
These valuation metrics place Laxmi Organic in the ‘expensive’ category, a downgrade from its prior ‘very expensive’ status as of 3 November 2025. The MarketsMOJO Mojo Score currently stands at 35.0, with a Mojo Grade of Sell, upgraded from a Strong Sell rating earlier. This suggests a slight improvement in sentiment but still signals caution for investors.
Comparative Analysis with Industry Peers
When compared with key competitors in the Specialty Chemicals industry, Laxmi Organic’s valuation multiples appear stretched. Bayer CropScience, for instance, trades at a P/E of 30.25 and EV/EBITDA of 23.38, both considerably lower than Laxmi Organic’s ratios. Anupam Rasayan, another peer, remains very expensive with a P/E of 92.01 and EV/EBITDA of 32.60, indicating that Laxmi Organic’s valuation is more moderate in comparison but still on the higher side.
Other companies such as BASF India and Sharda Cropchem present more attractive valuations, with P/E ratios of 36.81 and 12.77 respectively, and EV/EBITDA multiples well below Laxmi Organic’s. This disparity highlights the premium investors currently assign to Laxmi Organic, despite its relatively modest return on capital employed (ROCE) of 3.89% and return on equity (ROE) of 4.00%, which lag behind sector averages.
Price Performance and Market Context
Laxmi Organic’s current share price is ₹152.10, down 1.49% on the day from a previous close of ₹154.40. The stock has traded within a 52-week range of ₹107.45 to ₹240.60, reflecting significant volatility over the past year. Notably, the stock’s one-year return is -22.0%, underperforming the Sensex’s -7.5% return over the same period. Over three and five years, the stock has declined by 40.53% and 32.07% respectively, while the Sensex has gained 21.61% and 48.99% in those intervals.
This underperformance, coupled with elevated valuation multiples, suggests that investors are pricing in expectations of future growth or sector-specific advantages that have yet to materialise in earnings or returns.
Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.
- - Recent Top 1% qualifier
- - Impressive market performance
- - Sector leader
Financial Quality and Dividend Yield
Laxmi Organic’s financial quality indicators remain subdued. The company’s ROCE of 3.89% and ROE of 4.00% are modest, especially when juxtaposed with the high valuation multiples. This disparity raises questions about the sustainability of the current price levels without a corresponding improvement in profitability or capital efficiency.
The dividend yield is a mere 0.33%, offering limited income appeal to investors. This low yield, combined with the high P/E ratio, suggests that the stock is primarily valued for growth prospects rather than income generation.
Valuation Grade Shift and Investor Implications
The downgrade in valuation grade from very expensive to expensive reflects a subtle recalibration of market expectations. While the stock remains pricey relative to earnings and book value, the shift indicates a slight easing of the premium investors are willing to pay. This could be due to recent price corrections or a reassessment of growth prospects.
Investors should weigh this valuation shift against the company’s fundamentals and sector outlook. The Specialty Chemicals sector is competitive, with several peers offering more attractive valuations and stronger financial metrics. Laxmi Organic’s elevated multiples may limit upside potential unless accompanied by significant operational improvements or earnings growth.
Laxmi Organic Industries Ltd or something better? Our SwitchER feature analyzes this small-cap Specialty Chemicals stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Historical Performance Versus Market Benchmarks
Over the short term, Laxmi Organic’s stock has shown mixed performance. The one-month return of 8.45% outpaced the Sensex’s decline of 0.85%, suggesting some recent positive momentum. However, the one-week return was negative at -3.03%, contrasting with the Sensex’s 1.08% gain, indicating volatility and uncertainty.
Longer-term returns paint a less favourable picture. The year-to-date return of -10.08% closely mirrors the Sensex’s -10.81%, but the one-year and three-year returns reveal significant underperformance. The stock’s 1-year loss of 22.0% is nearly triple the Sensex’s 7.5% decline, while the three-year loss of 40.53% starkly contrasts with the Sensex’s 21.61% gain. This trend extends to five years, where Laxmi Organic’s -32.07% return is dwarfed by the Sensex’s 48.99% appreciation.
These figures underscore the challenges the company faces in delivering shareholder value relative to broader market indices.
Conclusion: Valuation Attractiveness and Investor Strategy
Laxmi Organic Industries Ltd’s recent valuation grade adjustment from very expensive to expensive signals a modest improvement in price attractiveness, yet the stock remains richly valued compared to peers and historical norms. Elevated P/E and EV/EBITDA multiples, coupled with subdued profitability metrics, suggest that investors are pricing in growth that has yet to be realised.
Given the company’s underwhelming long-term returns relative to the Sensex and more attractively valued competitors within the Specialty Chemicals sector, investors should approach the stock with caution. The current Mojo Grade of Sell reflects this cautious stance, despite the upgrade from Strong Sell.
For those considering exposure to the sector, it may be prudent to evaluate alternative stocks with stronger fundamentals and more reasonable valuations, particularly given the availability of multi-parameter analyses that identify superior investment candidates.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
